discovery synthesis

Oligonucleotide CRDMO Platform: Discovery to Commercial Manufacturing

This platform delivers full CRDMO services for oligonucleotides, covering discovery synthesis at nmol-mmol scales up to mol-scale commercial production. It includes monomers, linkers, ligands, conjugates, formulation, analytical testing, and CMC dossier preparation under a single quality system. Capabilities span DNA, ASOs, siRNAs, and more, with global regulatory approvals from FDA, EMA, and others.